tiprankstipranks
Trending News
More News >
Together Pharma Ltd. (IL:TGTR)
:TGTR
Israel Market
Advertisement

Together (TGTR) Ratios

Compare
0 Followers

Together Ratios

IL:TGTR's free cash flow for Q4 2024 was -0.04. For the 2024 fiscal year, IL:TGTR's free cash flow was decreased by and operating cash flow was -0.20. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.07 1.46 1.25 1.32 2.12
Quick Ratio
0.36 0.35 0.31 0.62 0.40
Cash Ratio
0.11 0.07 0.11 0.08 0.27
Solvency Ratio
0.04 <0.01 -0.22 -0.06 0.10
Operating Cash Flow Ratio
0.04 0.30 -0.29 -0.28 -0.45
Short-Term Operating Cash Flow Coverage
0.07 0.88 -0.63 -0.41 -1.98
Net Current Asset Value
-24.34M -68.36M -67.46M -45.70M -65.08M
Leverage Ratios
Debt-to-Assets Ratio
0.43 0.40 0.45 0.53 0.46
Debt-to-Equity Ratio
1.91 -7.03 -137.73 4.11 6.90
Debt-to-Capital Ratio
0.66 1.17 1.01 0.80 0.87
Long-Term Debt-to-Capital Ratio
0.23 1.44 1.02 0.59 0.84
Financial Leverage Ratio
4.41 -17.78 -304.68 7.69 15.11
Debt Service Coverage Ratio
0.23 1.40 -0.39 0.10 1.15
Interest Coverage Ratio
0.00 0.00 -1.16 -0.77 1.40
Debt to Market Cap
0.79 1.16 2.31 1.15 0.34
Interest Debt Per Share
4.96 6.24 9.44 16.11 11.78
Net Debt to EBITDA
6.17 1.85 -3.72 -12.98 2.50
Profitability Margins
Gross Profit Margin
18.23%38.04%-18.85%-18.07%-52.03%
EBIT Margin
3.41%24.28%-63.31%-95.27%148.18%
EBITDA Margin
9.30%30.35%-46.01%-51.04%183.15%
Operating Profit Margin
3.41%24.28%-63.31%-95.27%148.18%
Pretax Profit Margin
-2.30%1.69%-116.33%-125.69%126.20%
Net Profit Margin
-1.22%-4.74%-107.35%-114.55%63.73%
Continuous Operations Profit Margin
-1.69%-2.78%-113.61%-125.69%137.87%
Net Income Per EBT
52.96%-280.44%92.29%91.14%50.50%
EBT Per EBIT
-67.63%6.97%183.75%131.94%85.17%
Return on Assets (ROA)
-0.80%-3.12%-25.83%-8.68%5.71%
Return on Equity (ROE)
-3.16%55.38%7869.48%-66.78%86.28%
Return on Capital Employed (ROCE)
4.80%24.91%-23.97%-12.39%16.02%
Return on Invested Capital (ROIC)
2.16%-33.96%-19.17%-1.58%13.88%
Return on Tangible Assets
-0.96%-3.91%-34.14%-11.11%8.21%
Earnings Yield
-2.44%-11.80%-162.64%-20.98%5.02%
Efficiency Ratios
Receivables Turnover
5.66 7.21 3.74 13.17 8.41
Payables Turnover
3.68 4.10 3.97 2.29 2.32
Inventory Turnover
1.39 1.02 0.83 0.31 0.46
Fixed Asset Turnover
2.71 2.57 0.85 0.35 0.32
Asset Turnover
0.65 0.66 0.24 0.08 0.09
Working Capital Turnover Ratio
16.91 5.22 1.89 0.53 3.26
Cash Conversion Cycle
227.30 319.28 444.10 1.06K 673.41
Days of Sales Outstanding
64.54 50.64 97.59 27.71 43.42
Days of Inventory Outstanding
262.01 357.73 438.51 1.20K 787.29
Days of Payables Outstanding
99.25 89.09 92.00 159.61 157.30
Operating Cycle
326.55 408.37 536.09 1.22K 830.71
Cash Flow Ratios
Operating Cash Flow Per Share
0.22 1.69 -1.71 -3.02 -1.65
Free Cash Flow Per Share
0.11 1.59 -1.75 -3.26 -4.00
CapEx Per Share
0.12 0.10 0.04 0.25 2.34
Free Cash Flow to Operating Cash Flow
0.48 0.94 1.02 1.08 2.42
Dividend Paid and CapEx Coverage Ratio
1.93 17.13 -41.24 -12.19 -0.71
Capital Expenditure Coverage Ratio
1.93 17.13 -41.24 -12.19 -0.71
Operating Cash Flow Coverage Ratio
0.04 0.27 -0.23 -0.22 -0.17
Operating Cash Flow to Sales Ratio
0.03 0.16 -0.44 -1.55 -0.86
Free Cash Flow Yield
2.11%38.16%-68.24%-30.73%-16.45%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-40.92 -8.48 -0.61 -4.77 19.94
Price-to-Sales (P/S) Ratio
0.68 0.40 0.66 5.46 12.71
Price-to-Book (P/B) Ratio
1.44 -4.70 -48.38 3.18 17.20
Price-to-Free Cash Flow (P/FCF) Ratio
47.29 2.62 -1.47 -3.25 -6.08
Price-to-Operating Cash Flow Ratio
16.84 2.47 -1.50 -3.52 -14.70
Price-to-Earnings Growth (PEG) Ratio
-0.38 0.10 >-0.01 0.02 -0.15
Price-to-Fair Value
1.44 -4.70 -48.38 3.18 17.20
Enterprise Value Multiple
13.45 3.18 -5.15 -23.68 9.44
Enterprise Value
120.10M 87.80M 73.99M 145.32M 194.06M
EV to EBITDA
13.45 3.18 -5.15 -23.68 9.44
EV to Sales
1.25 0.96 2.37 12.08 17.29
EV to Free Cash Flow
87.41 6.29 -5.26 -7.20 -8.27
EV to Operating Cash Flow
42.16 5.92 -5.39 -7.79 -20.00
Tangible Book Value Per Share
1.05 -3.50 -3.56 -1.44 -3.98
Shareholders’ Equity Per Share
2.60 -0.89 -0.05 3.34 1.41
Tax and Other Ratios
Effective Tax Rate
0.27 2.65 -0.02 0.81 0.09
Revenue Per Share
7.50 10.36 3.89 1.95 1.91
Net Income Per Share
-0.09 -0.49 -4.18 -2.23 1.22
Tax Burden
0.53 -2.80 0.92 0.91 0.50
Interest Burden
-0.68 0.07 1.84 1.32 0.85
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.09 0.08 0.24 0.72 0.97
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.12 0.36
Income Quality
-2.43 -3.44 0.41 1.35 -1.36
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis